$IRWD Headlines Ironwood Pharma loss widens as e

$IRWD Headlines

Ironwood Pharma loss widens as expenses soar 8:00 a.m. April 23, 2013 - MarketWatch.com
FDA approves Ironwood's drug for IBS 10:40 a.m. Aug. 30, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 5:06 p.m. March 5, 2012 - Kate Gibson
Ironwood pins hopes on Linaclotid 10:37 a.m. Aug. 16, 2011 - MarketWatch.com
Abolish the FDA; it's insane 9:55 a.m. July 27, 2011 - James Altucher
Ironwood Pharma rallies on positive Phase 3 trial 7:39 a.m. Sept. 14, 2010 - Steve Gelsi

Nothing Should Iritate You About Synergy's Upcoming Catalysts 7:16 a.m. Nov. 6, 2013 - Seeking Alpha
Nothing Should Irritate You About Synergy's Upcoming Catalysts 7:16 a.m. Nov. 6, 2013 - Seeking Alpha
Pipeline Progress at Synergy Pharma - Analyst Blog 5:00 p.m. Nov. 4, 2013 - Zacks.com
10-Q: IRONWOOD PHARMACEUTICALS INC 4:08 p.m. Oct. 28, 2013 - Edgar Online - (EDG = 10Q, 10K)
Weekly 3-Year Low Highlight: EXC, RVBD, IRWD, SHOS 3:50 p.m. Oct. 27, 2013 - GuruFocus.com
UPDATE: Cowen & Company Upgraded Ironwood Pharmaceuticals 2:14 p.m. Oct. 24, 2013 - benzinga.com
First Week Of IRWD December 21st Options Trading 11:52 a.m. Oct. 23, 2013 - TheStreet.com
Ironwood Slips into Loss in Q3 - Analyst Blog 11:00 a.m. Oct. 23, 2013 - Zacks.com
Ironwood Pharmaceuticals Is Now Oversold (IRWD) 4:17 p.m. Oct. 22, 2013 - TheStreet.com
Ironwood Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript 12:20 p.m. Oct. 22, 2013 - Seeking Alpha
Five-Year Lows: Singapore Airlines Limited, Gold Field Ltd., Ironwood Pharmaceuticals Inc. ... 10:04 a.m. Oct. 22, 2013 - GuruFocus.com
Data on Auxilium Pharma's Xiaflex - Analyst Blog 4:35 p.m. Oct. 11, 2013 - Zacks.com
Discovery Labs Surges on Surfaxin News - Analyst Blog 4:15 p.m. Oct. 7, 2013 - Zacks.com
Forest's Patent Infringement Lawsuits - Analyst Blog 1:30 p.m. Oct. 7, 2013 - Zacks.com
Synergy Pharma's Pipeline Holds Promise - Analyst Blog 6:30 p.m. Oct. 4, 2013 - Zacks.com
Ironwood's Linzess Sales Are Ramping Up: Buy The Dip? 9:35 a.m. Sept. 19, 2013 - Seeking Alpha
Ironwood and AstraZeneca Initiate Study - Analyst Blog 4:30 p.m. Sept. 16, 2013 - Zacks.com
Positive News on Roche's Perjeta - Analyst Blog 2:30 p.m. Sept. 13, 2013 - Zacks.com
Data on Novartis' Ultibro Breezhaler - Analyst Blog 5:32 p.m. Sept. 12, 2013 - Zacks.com
Roche and Inovio Tie Up - Analyst Blog 12:00 p.m. Sept. 11, 2013 - Zacks.com


Upcoming Earnings Schedules, Conferences and Quarterly Financial Results - Research Report on Supernus, Ironwood, Neurocrine Biosciences, PhotoMedex, and Kythera 8:00 a.m. Nov. 11, 2013 - PR Newswire
Ironwood Pharmaceuticals to Present at Credit Suisse 2013 Healthcare Conference 4:00 p.m. Nov. 6, 2013 - BusinessWire
Partnership, Quarterly Reports, Acquisition, and Publication - Research Report on Alere, Ironwood, Magellan Health Services, Foundation Medicine, and InterMune 8:00 a.m. Oct. 28, 2013 - PR Newswire
Ironwood Pharmaceuticals Provides Third Quarter 2013 Investor Update 6:10 a.m. Oct. 22, 2013 - BusinessWire
Ironwood Pharmaceuticals to Host Third Quarter 2013 Investor Update Call 3:00 p.m. Oct. 8, 2013 - BusinessWire
Dividend Increases, Research Nominations, New Treatment Options, and Clinical Trials - Research Report on Covidien, Ironwood, ICON, Novadaq, and Antares 7:00 a.m. Oct. 2, 2013 - PR Newswire
Ironwood and AstraZeneca Initiate Linaclotide Phase III Trial in China for Adults with IBS-C 7:00 a.m. Sept. 10, 2013 - BusinessWire
Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference 3:00 p.m. Sept. 3, 2013 - BusinessWire
Positive Clinical Trial Results, Regulatory Wins, and New Appointments - Research Report on Incyte, Edwards, ACADIA Pharmaceuticals, Alnylam, and Ironwood 7:00 a.m. Aug. 26, 2013 - PR Newswire
Ironwood Pharmaceuticals Appoints Dr. Michael Hall as Senior Vice President of Clinical Development 7:00 a.m. Aug. 21, 2013 - BusinessWire
Earnings Releases, Investment Plans, Commencement of Clinical Trials, and FDA Applications Brighten Outlook - Research Report on Bard, Centene, Exact Sciences, Ironwood, and Merrimack 7:00 a.m. July 26, 2013 - PR Newswire
RDInvesting Provides Investors with Free In-Depth Equity Reports on DHI, EZCH, IRWD and NUE 7:31 a.m. July 25, 2013 - ACCESSWIRE
Ironwood Pharmaceuticals Provides Second Quarter 2013 Investor Update 6:05 a.m. July 23, 2013 - BusinessWire
Ironwood Pharmaceuticals to Host Second Quarter 2013 Investor Update Call 3:00 p.m. July 9, 2013 - BusinessWire
Innovative Technologies that Yield Improved Treatments - Research Report on Mettler-Toledo, Ironwood, Covance, Teleflex and WuXi 7:00 a.m. June 26, 2013 - PR Newswire
Ironwood Pharmaceuticals Announces Partial Exercise of Underwriters' Option in Public Offering of Common Stock 3:00 p.m. June 4, 2013 - BusinessWire
Further Expansions and Positive Study Results Drive Healthcare Companies - Research Report on Agilent, Thermo Fisher, BG Medicine, Quest Diagnostics, and Ironwood Pharmaceuticals 7:00 a.m. May 31, 2013 - PR Newswire
Ironwood Pharmaceuticals Prices Public Offering of Common Stock 5:30 p.m. May 21, 2013 - BusinessWire
Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock 3:05 p.m. May 20, 2013 - BusinessWire
Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week(R) 2013 7:00 a.m. May 14, 2013 - BusinessWire